Application of specific lectin composition in preparing test carrier for identifying epithelial ovarian cancer, and kit
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 深圳格道糖生物技术有限公司
- Publication Date
- 2018-06-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the use and kit of a lectin for identifying epithelial ovarian cancer based on salivary glycoprotein. Background technique
[0002] Ovarian cancer (Ovarian cancer, OC) is one of the most common tumors of the female reproductive system, ranking sixth among the most common cancers in the world, fifth among common female cancers, and seventh among the major cancers that cause death in women globally . In recent years, the incidence of ovarian cancer in my country has been on the rise. It is estimated that the incidence of ovarian cancer in my country will reach 6.43 / 100,000 in 2016. Due to the lack of obvious differential signs and screening methods, early diagnosis of ovarian cancer is very difficult. Clinical studies have shown that the 5-year survival rate of ovarian cancer patients diagnosed in the early stage (I / II) can reach more than 90%, however, about 70%-85% of the patients are already in the advanced stage (III / IV stag...